Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

News archive

First paper published from PhD research

Tuesday, 6 November 2018 3:52pm

PhD candidate Sarah Donald and her supervisory team have published the first paper from her PhD research.

^ Top of Page

No increased risk of lung infections among infants using popular anti-reflux medicines

Tuesday, 18 September 2018 10:16am

New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies.

^ Top of Page

PhD candidate receives award

Thursday, 31 May 2018 12:07pm

Sarah Donald has received a prize in the 2018 Dunedin School of Medicine postgraduate poster competition for a poster which outlines the process of generating a pregnancy cohort for medicine utilisation and safety studies in New Zealand.

^ Top of Page

Prescribing guidelines not always followed for patients on cholesterol-lowering drug

Friday, 4 May 2018 10:40am

New Zealand prescribers do not always follow guidelines when prescribing other medicines to patients taking simvastatin, according to University of Otago researchers from the Pharmacoepidemiology Research Network. 

^ Top of Page

Chronic lung disease treatment in New Zealand often not consistent with international guidelines

Tuesday, 19 December 2017 10:53am

University of Otago researchers have found that the treatment of chronic obstructive pulmonary disease (COPD) in New Zealand frequently does not conform to international guidelines.

^ Top of Page

No evidence higher doses of cholesterol-lowering drug increase risk of acute kidney damage

Monday, 31 July 2017 3:37pm

New Zealanders taking a higher dose of simvastatin, one of the cholesterol-lowering statin drugs used to prevent heart attacks and strokes, do not appear to have a higher risk of acute kidney damage than those taking a lower dose, according to University of Otago researchers from the Pharmacoepidemiology Research Network.

^ Top of Page

Researchers funded to investigate possible adverse effect of a common lung disease treatment

Thursday, 15 June 2017 9:23am

The University of Otago’s Dr Lianne Parkin and colleagues will receive a Health Research Council grant to investigate whether particular drugs used to treat a common lung disease put people at greater risk of heart attacks.

^ Top of Page

Off-label prescription of proton pump inhibitors to New Zealand infants is common

Thursday, 4 May 2017 12:09pm

Off-label use of proton pump inhibitors is common among New Zealand infants, according to new University of Otago research.

^ Top of Page

Otago researchers receive new joint pharmaceuticals research funding

Thursday, 2 March 2017 4:32pm

Researchers from University of Otago are among the first recipients of two new grants from PHARMAC and the Health Research Council of New Zealand (HRC).

^ Top of Page

Disparities in insulin pump use by New Zealanders with type 1 diabetes: Otago research

Friday, 23 September 2016 11:32am

There are significant demographic and regional disparities in the use of insulin pumps in New Zealand, according to new University of Otago research.